+91 789 2456 581 | info@nckpharma.com

Please sign in first

Username

Password

Lost Your Password?

Not a member?

Please simply create an account before buying/booking any courses.

Create an account for free!

Home
- About Us
- Contact
NCK services
Course List
Admission
Corporate Training
Knowledge Base

Home
- About Us
- Contact
NCK services
Course List
Admission
Corporate Training
Knowledge Base

Tag

Hepcvir-L

Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India

Posted on25 Dec 2015

TagsBiocon, Biocon launched Gilead Sciences' Hepatitis C drug - CIMIVIR-L in India, CIMIVIR-L, Cipla, Gilead Sciences, Hepcvir-L

Comments0

BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The...

Our Popular Courses

Pharma Product Management
Digital Pharma Marketing
Strategic Management
Regulatory Affairs
Pharma Marketing
European DRA
Sales Management
Pharmacovigilance
Production Management
ASEAN DRA
GCC DRA
Pharma Project Management
Export Documentation

Recent Articles

Insight on Alteogen’s non-exclusive licensing deal for ALT-B4 to a top 10 global pharma
Pharma Strategic Deal: Astellas Pharma to acquire Audentes Therapeutics for about $3 billion
Pharma Business Development – Competency Test. Check your competency
Case study: Novartis to acquire The Medicines Company for $9.7 billion, get hold of inclisiran, a cholesterol drug
What is USFDA Purple Book? What it’s significance?
USFDA approved Pfizer’s Abrilada, a biosimilar of Humira
Pfizer’s Upjohn and Mylan merged business entity will be namea as Viatris
Bayer and Dewpoint Therapeutics co-development deal for cardiovascular and gynecological diseases
Sandoz to Acquire Japanese Biz of AGI
Selumetinib NDA Submission for Neurofibromatosis Type 1 (NF1) granted Priority Review
Insignt on Roche’s Up-to-$1.4Billion Promedior Acquisition
Case Study: 505(b)(2) filing pathway – USFDA approval of Vumerity
What is the significance of Clinical Hold of investigational molecules?
US FDA places partial hold on Novartis’ AVXS-101 intrathecal study
Zentiva to acquire CEE pharma business of Alvogen
Insighht on USFDA approval of Trikafta
How much is the average ideal royalty rate in pharmaceutical and biopharmaceutical business deal?
Pharma Licensing: Explore differences between Royalty rate & Royalty base
Takeda Divesting Select OTC and Non-core Assets of takeda to Acino
GSK to disinvest Rabipur and Encepur – vaccine for USD 1.1 billion

Course Category

KPE® – Certificate Program (1 Month)
KPE® – Certificate Program (1 Week)
KPE® – Publications / White Papers / Workshop / Others
KPE® Advance Diploma Program (1 Year Program)
KPE® Advance Diploma Program – Dual Specialization (1 Year Program)
KPE® Executive Program (1 Year Program)

Certification Courses

View our online Certification Courses.

Corporate Training

View list of courses, simulation, e-books, libararies for Pharma Corporate, Government and Regulatory Bodies.

Subscribe to NCK Newsline

Enter your email address:

Delivered by FeedBurner

Popular 1 Year Courses

KPE – C- 024 KPE’s Executive Program in Pharmaceutical Global Business
KPE-C-001 KPE’s Advance Diploma in Pharmaceutical Product Management
KPE-C-003 KPE’s Advance Diploma in Drug Regulatory Affairs
KPE-C-004 KPE’s Advance Diploma in Pharma Marketing
KPE – C- 009 KPE’s Advance Diploma in Pharmacovigilance
KPE-C-005 KPE’s Advance Diploma in Pharmaceutical Production management
KPE-C-08 KPE’s Advance Diploma in Pharmaceutical Strategic Business Management

Javascript is disabled

Javascript is disabled on your browser. Please enable it in order to use this form.

Loading

Query

First Name

Last Name

Email Address

Your Query *

Write Here

10 plus 5 equals?*

Prove you are a human

Write here

Your form has been submitted

Thank you %NAME% for the submitting your query/feedback.

Server Side Error

We faced problems while connecting to the server or receiving data from the server. Please wait for a few seconds and try again.

If the problem persists, then check your internet connectivity. If all other sites open fine, then please contact the administrator of this website with the following information.

TextStatus: undefined
HTTP Error: undefined

Processing your request

Error

Some error has occured.

Disclaimer & Privacy Policy | Terms of Use

Copyright © 2014 - 2015 All Right Reserved - NCK Pharma Solution Private Limited

This website uses cookies to improve your learning experience. Ok Privacy Policy

Privacy & Cookies Policy

Necessary Always Enabled

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests

etc.